Clinical Trials Browser

Phase 1 × Terminated × Blood Component Removal × Clear all

NCT00048100 2018-10-31

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute